Stock Price & Analysis

Based on the provided data and recent market activity, here's a concise analysis for TMHC:

Technical Analysis

The stock is currently trading at $64.18, showing a modest gain of 0.36% in the last session. Key technical indicators suggest:

• RSI-14 at 50.30 indicates neutral momentum
• MACD shows slight bearish divergence (-0.21)
• Stock is trading near its 20-day moving average of $64.67
• Current price is within Bollinger Bands (BBL: $60.20, BBM: $64.67, BBU: $69.14)

Fundamental Strengths

• Strong financial performance with FY2022:
  • Revenue: $8.22B
  • Net Income: $1.05B
  • Healthy gross margin of 25.44%
  • Impressive ROE of 24.61%

Recent Developments According to recent analyst coverage:

• Barclays maintains a Buy rating with a $90 price target
• Strong Q3 2024 results with revenue of $2.12B and net profit of $251.13M
• Current analyst consensus price target is $78.00

Fibonacci Levels

• Resistance levels: R1: $65.52, R2: $66.67, R3: $68.52
• Support levels: S1: $61.82, S2: $60.67, S3: $58.82
• Pivot point: $63.67

Recommendation Based on the technical setup and strong fundamentals, TMHC appears to be in a consolidation phase with upside potential. The stock is showing resilience near its moving averages with strong analyst support. Consider buying at current levels with a stop loss below $61.82 (S1 level) and initial target at $66.67 (R2 level).

Based on the available data and analyst forecasts, here is the price prediction for TMHC stock in 2025:

Technical Analysis

The stock is currently trading at $64.18 and shows a wide and falling trend in the short term. Key technical levels:

• Support: $63.95
• Resistance: $64.22
• 52-week range: $53.17 - $75.49

Analyst Consensus & Price Targets

According to 6 Wall Street analysts:

• Average Price Target: $84.83 (32.18% upside)
• Highest Target: $90.00 (40.23% upside)
• Lowest Target: $74.00 (15.3% upside)

The consensus rating is "Strong Buy" with 6 out of 8 analysts recommending Buy.

Growth Drivers

1. Housing Market Recovery: The housing market is expected to improve modestly in 2025 as trends signal that the market already bottomed out in 2024.

2. Financial Performance:

• 2025 Revenue Forecast: $8.5B (4.1% growth)
• 2025 EPS Forecast: $9.33 (12.8% growth)
• 2026 Revenue Forecast: $9.0B (5.8% growth)
• 2026 EPS Forecast: $10.29 (10.3% growth)

Price Prediction for 2025: Based on technical analysis, fundamental growth drivers and analyst consensus, TMHC stock is expected to reach $84-85 by end of 2025, representing approximately 32% upside from current levels. The prediction is supported by:

1. Strong analyst consensus with multiple "Buy" ratings
2. Expected housing market recovery in 2025
3. Consistent earnings and revenue growth forecasts
4. Solid technical support levels around $63-64 range

The S1 support level for TMHC Stock is $60.95 ,The R1 resistant level for TMHC Stock is $65.27.

As of the end of day on 2025-02-21, the price of TMHC Stock was $60.79.

The target price for TMHC Stock according to analyst rating is 79.00, with the highest price target at 90.00 and the lowest at 55.00. Analysts have a Moderate Buy rating on TMHC Stock overall.

The market cap of TMHC is $6.2B.

Based on the provided data and current valuation metrics, TMHC appears to be fairly valued. The stock's P/E ratio of 7.4x for Q4 2024 is below the industry average, suggesting attractive valuation from an earnings perspective. The EV/EBITDA multiple of 6.58x indicates reasonable operational efficiency valuation. Recent analyst actions show positive sentiment, with RBC Capital maintaining a Buy rating and raising the price target to $74.

Key Analysis Points:

• Recent analyst ratings are predominantly bullish, with multiple upgrades and price target increases in Q4 2024 and early 2025.
• The stock is trading at $64.18 as of the last close, showing resilience despite industry headwinds.
• Technical indicators suggest the stock recently entered oversold territory with an RSI reading of 29.4, potentially presenting a buying opportunity.

Industry Context:

• The homebuilding sector faces challenges from elevated mortgage rates and construction costs.
• However, limited housing supply and strong demand for homeownership continue to support the industry's growth prospects.
• Taylor Morrison's focus on operational efficiency and strategic positioning in key markets helps maintain competitive advantages.

Conclusion: At current price levels, TMHC appears appropriately valued considering its financial metrics, analyst sentiment, and industry position. The stock's valuation multiples suggest it's neither significantly overvalued nor undervalued relative to peers and historical trends.

Taylor Morrison Home Corporation (Taylor Morrison) is a national land developer and homebuilder in the United States. The Company’s principal business is residential homebuilding and the development of lifestyle communities with operations across 11 states. The Company operates through four segments: East, Central, West and Financial Services. It provides an assortment of homes across a range of price points to appeal to an array of consumer groups. It designs, builds and sells single and multifamily detached and attached homes in traditionally high growth markets for entry level, move-up, and resort lifestyle buyers. It operates under various brand names, including Taylor Morrison, Darling Homes Collection by Taylor Morrison, and Esplanade. It also has a Build-to-Rent homebuilding business, which operates Yardly brand name. In addition, it develops and constructs multi-use properties consisting of commercial space, retail, and multifamily properties under the Urban Form brand name.

Based on the provided data and recent market analysis, here's the 2030 price prediction for TMHC stock:

TMHC stock is projected to reach $90-95 by 2030, driven by strong fundamentals and market positioning. The primary reasons are the company's consistent revenue growth trajectory and strategic expansion into new markets, particularly in the Gulf Coast region.

The housing market recovery expected in 2025 combined with TMHC's robust operational performance sets a strong foundation for long-term growth.

TMHC has a total of 2800 employees.